BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/7/2021 11:17:20 AM | Browse: 836 | Download: 1921
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 62422
Country United States
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Current controversies and advances in the management of pancreatic adenocarcinoma
Manuscript Source Invited Manuscript
All Author List Muhammad Shehroz Zeeshan and Zeeshan Ramzan
ORCID
Author(s) ORCID Number
Muhammad Shehroz Zeeshan http://orcid.org/0000-0001-6552-0355
Zeeshan Ramzan http://orcid.org/0000-0003-2989-8304
Funding Agency and Grant Number
Corresponding Author Zeeshan Ramzan, AGAF, FACG, Associate Professor, Gastrointestinal Section, Department of Medicine, Texas Health Harris Methodist Hospital, 1301 Pennsylvania Ave, Fort Worth, TX 76104, United States. zeeshanramzan@hotmail.com
Key Words Pancreatic adenocarcinoma; Advances in management; Imaging; Novel approaches; Chemotherapy; Controversies
Core Tip Early diagnosis and treatment of pancreatic adenocarcinoma has remained a challenge over the last several decades. Despite best efforts, the long-term survival rate has not significantly improved. The following manuscript highlights the current advances and controversies in the management of pancreatic cancer. The standard systemic therapies have been presented in a format that is easy to read and follow. Novel approaches in diagnosis and management have been discussed in light of evidence-based medicine.
Publish Date 2021-06-07 11:17
Citation Zeeshan MS, Ramzan Z. Current controversies and advances in the management of pancreatic adenocarcinoma. World J Gastrointest Oncol 2021; 13(6): 472-494
URL https://www.wjgnet.com/1948-5204/full/v13/i6/472.htm
DOI https://dx.doi.org/10.4251/wjgo.v13.i6.472
Full Article (PDF) WJGO-13-472.pdf
Full Article (Word) WJGO-13-472.docx